Atlas Trials

Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

Clinical trial NCT05778591 · RECRUITING

Trial details

NCT number
NCT05778591
Sponsor
University of California, Los Angeles
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2024-05-17
Primary completion
2026-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.